Recknor CP - Search Results

1

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures.

Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, García-Hernández PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. Aspenberg P, et al. Among authors: recknor cp. J Bone Miner Res. 2010 Feb;25(2):404-14. doi: 10.1359/jbmr.090731. J Bone Miner Res. 2010. PMID: 19594305 Free article. Clinical Trial.

2

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.

Recker RR, Kendler D, Recknor CP, Rooney TW, Lewiecki EM, Utian WH, Cauley JA, Lorraine J, Qu Y, Kulkarni PM, Gaich CL, Wong M, Plouffe L Jr, Stock JL. Recker RR, et al. Among authors: recknor cp. Bone. 2007 Apr;40(4):843-51. doi: 10.1016/j.bone.2006.11.001. Epub 2006 Dec 19. Bone. 2007. PMID: 17182297 Clinical Trial.

3

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.

Miller PD, Delmas PD, Lindsay R, Watts NB, Luckey M, Adachi J, Saag K, Greenspan SL, Seeman E, Boonen S, Meeves S, Lang TF, Bilezikian JP; Open-label Study to Determine How Prior Therapy with Alendronate or Risedronate in Postmenopausal Women with Osteoporosis Influences the Clinical Effectiveness of Teriparatide Investigators. Miller PD, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):3785-93. doi: 10.1210/jc.2008-0353. Epub 2008 Aug 5. J Clin Endocrinol Metab. 2008. PMID: 18682511 Free PMC article. Clinical Trial.

4

Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture.

Eriksen EF, Lyles KW, Colón-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Eriksen EF, et al. J Bone Miner Res. 2009 Jul;24(7):1308-13. doi: 10.1359/jbmr.090209. J Bone Miner Res. 2009. PMID: 19257818 Free PMC article. Clinical Trial.

5

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.

Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K. Devogelaer JP, et al. J Rheumatol. 2010 Jan;37(1):141-8. doi: 10.3899/jrheum.090411. Epub 2009 Nov 16. J Rheumatol. 2010. PMID: 19918047 Clinical Trial.

6

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.

Cosman F, Eriksen EF, Recknor C, Miller PD, Guañabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S. Cosman F, et al. J Bone Miner Res. 2011 Mar;26(3):503-11. doi: 10.1002/jbmr.238. J Bone Miner Res. 2011. PMID: 20814967 Free article. Clinical Trial.

7

Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.

Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR; HORIZON Pivotal Fracture Group. Cauley JA, et al. J Bone Miner Res. 2011 May;26(5):984-92. doi: 10.1002/jbmr.292. J Bone Miner Res. 2011. PMID: 21542001 Free PMC article. Clinical Trial.

8

The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.

Hadji P, Zanchetta JR, Russo L, Recknor CP, Saag KG, McKiernan FE, Silverman SL, Alam J, Burge RT, Krege JH, Lakshmanan MC, Masica DN, Mitlak BH, Stock JL. Hadji P, et al. Among authors: recknor cp. Osteoporos Int. 2012 Aug;23(8):2141-50. doi: 10.1007/s00198-011-1856-y. Epub 2011 Dec 13. Osteoporos Int. 2012. PMID: 22159672 Clinical Trial.

9

Discontinuation of denosumab and associated fracture incidence: analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) trial.

Brown JP, Roux C, Törring O, Ho PR, Beck Jensen JE, Gilchrist N, Recknor C, Austin M, Wang A, Grauer A, Wagman RB. Brown JP, et al. J Bone Miner Res. 2013 Apr;28(4):746-52. doi: 10.1002/jbmr.1808. J Bone Miner Res. 2013. PMID: 23109251 Free PMC article. Clinical Trial.

10

Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab.

Keaveny TM, McClung MR, Genant HK, Zanchetta JR, Kendler D, Brown JP, Goemaere S, Recknor C, Brandi ML, Eastell R, Kopperdahl DL, Engelke K, Fuerst T, Radcliffe HS, Libanati C. Keaveny TM, et al. J Bone Miner Res. 2014 Jan;29(1):158-65. doi: 10.1002/jbmr.2024. J Bone Miner Res. 2014. PMID: 23794225 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters